Short‐term interleukin‐37 treatment improves vascular endothelial function, endurance exercise capacity, and whole‐body glucose metabolism in old mice
Open Access
- 21 November 2019
- journal article
- research article
- Published by Wiley in Aging Cell
- Vol. 19 (1) , e13074
Abstract
Aging is associated with vascular endothelial dysfunction, reduced exercise tolerance, and impaired whole‐body glucose metabolism. Interleukin‐37 (IL‐37), an anti‐inflammatory cytokine of the interleukin‐1 family, exerts salutary physiological effects in young mice independent of its inflammation‐suppressing properties. Here, we assess the efficacy of IL‐37 treatment for improving physiological function in older age. Old mice (26–28 months) received daily intraperitoneal injections of recombinant human IL‐37 (recIL‐37; 1 µg/200 ml PBS) or vehicle (200 ml PBS) for 10–14 days. Vascular endothelial function (ex vivo carotid artery dilation to increasing doses of acetylcholine, ACh) was enhanced in recIL‐37 vs. vehicle‐treated mice via increased nitric oxide (NO) bioavailability (all p < .05); this effect was accompanied by enhanced ACh‐stimulated NO production and reduced levels of reactive oxygen species in endothelial cells cultured with plasma from IL‐37‐treated animals (p < .05 vs. vehicle plasma). RecIL‐37 treatment increased endurance exercise capacity by 2.4‐fold, which was accompanied by a 2.9‐fold increase in the phosphorylated AMP‐activated kinase (AMPK) to AMPK ratio (i.e., AMPK activation) in quadriceps muscle. RecIL‐37 treatment also improved whole‐body insulin sensitivity and glucose tolerance (p < .05 vs. vehicle). Improvements in physiological function occurred without significant changes in plasma, aortic, and skeletal muscle pro‐inflammatory proteins (under resting conditions), whereas pro‐/anti‐inflammatory IL‐6 was greater in recIL‐37‐treated animals. Plasma metabolomics analysis revealed that recIL‐37 treatment altered metabolites related to pathways involved in NO synthesis (e.g., increased L‐arginine and citrulline/arginine ratio) and fatty acid metabolism (e.g., increased pantothenol and free fatty acids). Our findings provide experimental support for IL‐37 therapy as a novel strategy to improve diverse physiological functions in old age.Keywords
Funding Information
- National Heart, Lung, and Blood Institute (HL007822, HL140875)
- National Institute on Aging (AG053804)
- National Institute of Allergy and Infectious Diseases (AI‐15614)
This publication has 56 references indexed in Scilit:
- Life-long caloric restriction reduces oxidative stress and preserves nitric oxide bioavailability and function in arteries of old miceAging Cell, 2013
- Nitrite supplementation reverses vascular endothelial dysfunction and large elastic artery stiffness with agingAging Cell, 2011
- IL-37 is a fundamental inhibitor of innate immunityNature Immunology, 2010
- Short‐term calorie restriction reverses vascular endothelial dysfunction in old mice by increasing nitric oxide and reducing oxidative stressAging Cell, 2010
- Fish oil supplementation improves endothelial function in normoglycemic offspring of patients with type 2 diabetesAtherosclerosis, 2009
- Pulse Pressure and Pulse Wave Velocity Are Related to Cognitive Decline in the Baltimore Longitudinal Study of AgingHypertension, 2008
- Interleukin-6 Is an Essential Regulator of Satellite Cell-Mediated Skeletal Muscle HypertrophyCell Metabolism, 2008
- Regulation of AMP-activated protein kinase and acetyl-CoA carboxylase phosphorylation by palmitate in skeletal muscle cellsJournal of Lipid Research, 2006
- AMPK activity is diminished in tissues of IL-6 knockout mice: the effect of exerciseBiochemical and Biophysical Research Communications, 2004
- Physical Fitness as a Predictor of Cardiovascular Mortality in Asymptomatic North American MenNew England Journal of Medicine, 1988